Michelle Donato

782 total citations
12 papers, 534 citations indexed

About

Michelle Donato is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Michelle Donato has authored 12 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 5 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Michelle Donato's work include Hematopoietic Stem Cell Transplantation (6 papers), Lymphoma Diagnosis and Treatment (3 papers) and Acute Myeloid Leukemia Research (2 papers). Michelle Donato is often cited by papers focused on Hematopoietic Stem Cell Transplantation (6 papers), Lymphoma Diagnosis and Treatment (3 papers) and Acute Myeloid Leukemia Research (2 papers). Michelle Donato collaborates with scholars based in United States and United Kingdom. Michelle Donato's co-authors include Sergio Giralt, Paolo Anderlini, Issa F. Khouri, Börje S. Andersson, Marcos de Lima, Cindy Ippoliti, Chitra Hosing, Richard E. Champlin, Naoto T. Ueno and James Gajewski and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and American Journal of Hematology.

In The Last Decade

Michelle Donato

12 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michelle Donato United States	9	337	201	176	111	105	12	534
Bachra Choufi France	9	279 0.8×	138 0.7×	103 0.6×	118 1.1×	83 0.8×	24	467
Ant Uzay Türkiye	8	254 0.8×	126 0.6×	95 0.5×	96 0.9×	60 0.6×	21	433
David Pohlreich Czechia	12	291 0.9×	182 0.9×	182 1.0×	219 2.0×	40 0.4×	21	540
A. Kashyap United States	6	324 1.0×	100 0.5×	103 0.6×	197 1.8×	109 1.0×	7	474
Lijda Vellekoop United States	10	231 0.7×	149 0.7×	167 0.9×	70 0.6×	54 0.5×	11	403
Sameh Gaballa United States	12	269 0.8×	169 0.8×	87 0.5×	98 0.9×	87 0.8×	55	413
Marta Morado Spain	11	339 1.0×	66 0.3×	125 0.7×	54 0.5×	59 0.6×	34	625
Jeremy Ramdial United States	10	121 0.4×	129 0.6×	86 0.5×	63 0.6×	30 0.3×	62	310
Lionello Camba Italy	6	146 0.4×	73 0.4×	89 0.5×	96 0.9×	30 0.3×	12	309
R. Vimercati Italy	11	273 0.8×	145 0.7×	119 0.7×	66 0.6×	56 0.5×	26	437

Countries citing papers authored by Michelle Donato

Since Specialization

Citations

This map shows the geographic impact of Michelle Donato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Donato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Donato more than expected).

Fields of papers citing papers by Michelle Donato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Donato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Donato. The network helps show where Michelle Donato may publish in the future.

Co-authorship network of co-authors of Michelle Donato

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Donato. A scholar is included among the top collaborators of Michelle Donato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Donato. Michelle Donato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Cook, Michael, Kepher H. Makambi, Yutong Luo, et al.. (2022). Toxicity and efficacy of CAR T-cell therapy in primary and secondary CNS lymphoma: a meta-analysis of 128 patients. Blood Advances. 7(1). 32–39. 61 indexed citations

Holstein, Sarah A., Sarah Cooley, Sundar Jagannath, et al.. (2019). A Phase I study of PNK-007, allogeneic, off the shelf NK cell, post autologous transplant in multiple myeloma (NCT02955550). Clinical Lymphoma Myeloma & Leukemia. 19(10). e112–e113. 2 indexed citations

Anderlini, Paolo, Rima M. Saliba, Sandra Acholonu, et al.. (2005). Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen. Bone Marrow Transplantation. 35(10). 943–951. 86 indexed citations

Wong, Raymond, Munir Shahjahan, Xuemei Wang, et al.. (2005). Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation. Biology of Blood and Marrow Transplantation. 11(2). 108–114. 85 indexed citations

Couriel, Daniel R., Rima M. Saliba, Sergio Giralt, et al.. (2004). Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation. Biology of Blood and Marrow Transplantation. 10(3). 178–185. 150 indexed citations

Ippoliti, Cindy, et al.. (2004). Elevated plasma levels of tacrolimus after concurrent use of tacrolimus and voriconazole in the bone marrow transplant setting. Biology of Blood and Marrow Transplantation. 10. 104–104. 1 indexed citations

Anderlini, Paolo, Sandra Acholonu, Grace‐Julia Okoroji, et al.. (2003). 26 Reduced early transplant-related mortality following allogeneic stem cell transplantation (SCT) with fludarabine-based, reduced-intensity conditioning from matched related and unrelated donors in advanced Hodgkin's disease (HD). Biology of Blood and Marrow Transplantation. 9(2). 71–71. 2 indexed citations

Couriel, Daniel R., Adam D. Cohen, Cindy Ippoliti, et al.. (2003). 15 Sirolimus (rapamycin) for treatment of steroid-refractory chronic graft versus host disease. Biology of Blood and Marrow Transplantation. 9(2). 67–68. 8 indexed citations

Shimoni, Avichai, D. Weber, Meletios Α. Dimopoulos, et al.. (2001). Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma. Bone Marrow Transplantation. 27(8). 821–828. 34 indexed citations

10.

Fayad, Luis, Paolo Anderlini, Naoto T. Ueno, et al.. (2001). Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia. American Journal of Hematology. 67(4). 227–233. 19 indexed citations

11.

Przepiorka, Donna, Koen van Besien, Brian L. Samuels, et al.. (1999). Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma. Annals of Oncology. 10(5). 527–529. 38 indexed citations

12.

Popat, Uday, Richard E. Champlin, William Pugh, et al.. (1998). High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome.. Journal of Clinical Oncology. 16(1). 63–69. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact